Demineralized Bone Matrix Market, By Product Type (Putty, Gel, Paste, Strips/Sheets, and Others), By Tissue Source (Allograft, and Xenograft), By Application (Spinal Fusion, Trauma, Foot and Ankle, Dental, and Other Applications), By End User (Hospitals,

Demineralized Bone Matrix Market, By Product Type (Putty, Gel, Paste, Strips/Sheets, and Others), By Tissue Source (Allograft, and Xenograft), By Application (Spinal Fusion, Trauma, Foot and Ankle, Dental, and Other Applications), By End User (Hospitals, Orthopedic Clinics, Academic and Research Institutes, Ambulatory Surgical Centers, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

The global demineralized bone matrix market has been growing steadily over the past few years. Demineralized bone matrix (DBM) is an osteobiologic material made from allogeneic bone after removing mineral components from the bone. It is utilized as a bone graft substitute in dental and orthopaedic procedures to stimulate bone formation. Rising number of dental surgeries and orthopaedic procedures due to increasing incidence of trauma injuries, bone fractures and various bone related diseases are some of the factors fueling demand for demineralized bone matrix globally. Moreover, growing awareness about advantages of DBM over autografts such as reduced donor site morbidity and greater availability is further supplementing the market growth. However, stringent regulations for approval of bone graft substitutes may restrain the market to a certain extent.

(Market Dynamics):

The key drivers propelling the growth of the global demineralized bone matrix market include rising geriatric population susceptible to bone disorders, increasing prevalence of dental diseases, growing number of spinal fusion and reconstruction surgeries, and advantages offered by DBM over conventional bone grafts. Additionally, ongoing research and development activities focused on enhancing osteoinductive properties of DBM through various techniques are creating new opportunities for market players. However, stringent regulatory framework for approval of bone graft substitutes and high costs associated with DBM products are some of the major challenges hampering the market growth. Moreover, preference for alternative bone grafting materials such as synthetic bone grafts is also restricting the market expansion to some extent.

(Key features of the study):

• This report provides in-depth analysis of the global demineralized bone matrix market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players such as Medtronic, Wright Medical Group, Stryker, J &J (DePuy Synthes), Zimmer Biomet, Xtant Medical, and Hans Biomed
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global demineralized bone matrix market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global demineralized bone matrix market.

Detailed Segmentation:

• Product Type Insights (Revenue, USD Bn, 2019 - 2031)
• Putty
• Gel
• Paste
• Strips/Sheets
• Others (Plugs, Fibers, etc.)
• Tissue Source Insights (Revenue, USD Bn, 2019 - 2031)
• Allograft
• Xenograft
• Application Insights (Revenue, USD Bn, 2019 - 2031)
• Spinal Fusion
• Trauma
• Foot and Ankle
• Dental
• Other Applications
• End user Insights (Revenue, USD Bn, 2019 - 2031)
• Hospitals
• Orthopedic Clinics
• Academic and Research Institutes
• Ambulatory Surgical Centers
• Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Medtronic plc
• Johnson & Johnson (DePuy Synthes)
• Zimmer Biomet
• Stryker
• SeaSpine
• Xtant Medical
• RTI Surgical
• HansBioMed
• Arthrex GmbH
• Exactech, Inc.
• AlloSource
• Halma (Novabone)
• Institut Straumann AG
• Orthofix Holdings, Inc.
• Straumann
• Synthes
• Integra LifeSciences
• Musculoskeletal Transplant Foundation (MTF)
• Bacterin International
• Osiris Therapeutics